Association of depressive symptoms and sleep disturbances with survival among US adult cancer survivors - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38835034/
Depressive symptoms were linked to a high risk of mortality in cancer survivors. The combination of a PHQ-9 score (≥ 5) and an absence of self-perceived sleep disturbances was associated...
https://pubmed.ncbi.nlm.nih.gov/38835034/
Depressive symptoms significantly increased all-cause, cancer-specific, and noncancer mortality risks in cancer survivors, particularly when sleep disturbances were absent, according to a NHANES-based cohort study.
Sleep and Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40149249/
Background/Objectives : Sleep issues are common in the general population, and these problems occur even more frequently for people with cancer. Sleep problems may pre-exist a patient's cancer diagnosis, and...
Sleep disorders commonly affect cancer patients, potentially influencing cancer progression via metabolic, immune, hormonal, and genetic pathways. Treating sleep issues may enhance outcomes and quality of life.
The effectiveness of exercise interventions in the improvement of sleep in older adult people: a meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40115345/
https://www.crd.york.ac.uk/PROSPERO/view/CRD42024530227, Identifier CRD42024530227.
Exercise interventions significantly improve sleep quality in older adults, reducing insomnia and enhancing sleep efficiency and duration, though effects on sleep onset and awakenings are less clear.
Effects of otolaryngological diseases on sleep quality, anxiety, and depression: a multicenter observational study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39948523/
Sleep quality significantly mediates the relationships of specific otolaryngological diseases with anxiety and depression. Similarly, anxiety and depression play important mediating roles in the relationships of different diseases with sleep...
https://pubmed.ncbi.nlm.nih.gov/39948523/
Otolaryngological diseases significantly affect sleep, anxiety, and depression, with interrelated impacts. Anxiety and depression mediate effects on sleep, highlighting the need for early psychological interventions.
https://pubmed.ncbi.nlm.nih.gov/39879708/
Lemborexant significantly improved total and REM sleep in patients with comorbid insomnia and mild obstructive sleep apnea, suggesting benefits for cognitive function and supporting its use in this population.